Context Capital Management LLC bought a new position in LAVA Medtech Acquisition Corp. (NASDAQ:LVAC – Get Rating) during the first quarter, Holdings Channel.com reports. The fund bought 225,000 shares of the company's stock, valued at approximately $2,246,000.
Other large investors have also made changes to their positions in the company. Starboard Value LP acquired a new position in LAVA Medtech Acquisition during the 4th quarter valued at $474,000. Fifth Lane Capital LP acquired a new stake in shares of LAVA Medtech Acquisition during the 4th quarter worth about $986,000. Radcliffe Capital Management L.P. acquired a new stake in shares of LAVA Medtech Acquisition during the 4th quarter worth about $1,000,000. Oaktree Capital Management LP acquired a new stake in shares of LAVA Medtech Acquisition during the 4th quarter worth about $2,500,000. Finally, Toronto Dominion Bank acquired a new stake in shares of LAVA Medtech Acquisition during the 1st quarter worth about $2,994,000. Institutional investors and hedge funds own 31.65% of the company's stock.
Get
LAVA Medtech Acquisition alerts:
LAVA Medtech Acquisition Trading Up 0.1 %
Shares of LAVA Medtech Acquisition stock opened at $10.06 on Thursday. The company has a 50-day simple moving average of $10.00 and a 200 day simple moving average of $9.97. LAVA Medtech Acquisition Corp. has a 12-month low of $9.83 and a 12-month high of $10.06.
LAVA Medtech Acquisition Company Profile
(Get Rating)
LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company focuses on pursuing opportunities in healthcare and healthcare-related industries.
Read More
- Get a free copy of the StockNews.com research report on LAVA Medtech Acquisition (LVAC)
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
- 3 Stable Growth Stocks for Bumpy Times
- Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
- The 2 Dow Stocks with Decade-Long Win Streaks on the Line
- Could Rite Aid Be an Acquisition Target, Again?
Want to see what other hedge funds are holding LVAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LAVA Medtech Acquisition Corp. (NASDAQ:LVAC – Get Rating).
Receive News & Ratings for LAVA Medtech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LAVA Medtech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
據Holdings Channel.com報道,上下文資本管理公司在第一季度收購了熔岩醫療技術收購公司(納斯達克代碼:LVAC-GET Rating)的一個新頭寸。該基金購買了225,000股該公司股票,價值約2,246,000美元。
其他大型投資者也改變了他們在該公司的頭寸。Starboard Value LP在第四季度收購了熔岩醫療技術公司,價值474,000美元。Five Lane Capital LP在第四季度收購了Lava Medtech收購的新股份,價值約98.6萬美元。Radcliffe Capital Management L.P.在第四季度收購了Lava Medtech收購的新股份,價值約100萬美元。橡樹資本管理有限公司在第四季度收購了熔岩醫療技術收購的新股份,價值約250萬美元。最後,多倫多道明銀行在第一季度收購了熔岩醫療技術公司的股份,價值約2994,000美元。機構投資者和對沖基金持有該公司31.65%的股票。
到達
收購熔岩醫療技術公司警報:
熔岩醫療技術收購交易上漲0.1%
週四,Lava Medtech收購股票的開盤價為10.06美元。該公司的50日簡單移動均線切入位在10.00美元,200日簡單移動均線切入位在9.97美元。熔岩醫療技術收購公司的股價為9.83美元的12個月低點和10.06美元的12個月高位。
熔岩醫療技術收購公司簡介
(獲取評級)
熔岩醫療技術收購公司沒有重要的業務。它打算通過合併、資本換股、資產收購、股票購買和重組來收購資產和業務。該公司專注於在醫療保健和醫療保健相關行業尋求機會。
閱讀更多內容
- 免費獲取StockNews.com關於Lva Medtech收購(LVAC)的研究報告
- 清潔能源法案通過後,太陽能股大放異彩
- 顛簸時代的3只穩定成長股
- 大型和小型石油和天然氣類股盈利後反彈
- 連續十年上漲的兩只道指股票
- Rite Aid會再次成為收購目標嗎?
想看看還有哪些對沖基金持有拉斯維加斯金沙集團嗎?訪問HoldingsChannel.com獲取熔岩醫療技術收購公司(納斯達克代碼:LVAC-GET Rating)的最新13F備案檔案和內幕交易資訊。
獲得熔岩醫療技術收購日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊,接收對Lava Medtech收購和相關公司的最新新聞和分析師評級的每日摘要。